Both in Biotechnology
Compass Therapeutics vs Coherus Oncology
Over the past year CMPX returned −79.9% and CHRS returned −49.6%; their daily moves had a correlation of 0.05.
CMPX −79.9% CHRS −49.6%Growth of $1, one year, split-adjusted
| Metric | CMPX | CHRS |
|---|---|---|
| Price | $0.7530 | $0.8056 |
| Market cap | $135.6M | $124.5M |
| Today | −1.89% | +7.50% |
| 1 month | −21.6% | −28.1% |
| 6 months | −61.4% | −55.0% |
| Year to date | −86.0% | −43.3% |
| 1 year | −79.9% | −52.0% |
| Revenue growth (YoY) | — | +39.5% |
| Gross margin | — | 70.4% |
| Net margin | — | −144.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.4× |
| Net cash | $179.9M | $68.1M |
| Dividend yield | — | — |
| Volatility (60d) | 100.4% | 94.6% |
| Short % of float | 33.9% | 9.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).